Subscribe
Logo small
Search

AOTMiT: What will the Transparency Council address in November?

MedExpress Team

medexpress.pl

Published Nov. 3, 2023 08:32

AOTMiT has published the Transparency Council's work plan from November 1 to 30.
AOTMiT: What will the Transparency Council address in November? - Header image
Źródło: AOTMiT

TRANSPARENCY COUNCIL MEETING NO. 44/2023 NOVEMBER 6, 2023

1. tezspire (tezepelumab) Indication: under drug program B.44. Treatment of patients with severe asthma (ICD-10: J45, J82) Decision problem: preparing a position paper on the evaluation of the drug

2. "Health policy program for the residents of the Municipality of Slawno in the field of medical rehabilitation for 2023-2027" Decision-making problem: preparation of an opinion on the draft health policy program of the local government unit

3. "Health policy program on prevention and early detection of lifestyle diseases in children and adolescents "6-10-14 for Health" for 2024-2026". Decision-making problem: preparing an opinion on the draft health policy program of a local government unit

4. "Subsidy for infertility treatment by in vitro fertilization for residents of the City of Przemyśl for 2024-2026". Decision-making problem: preparation of an opinion on the draft health policy program of a local government unit

TRANSPARENCY COUNCIL MEETING NO. 45/2023 NOVEMBER 13, 2023

1. repatha (evolocumabum) Indication: under drug program B.101 "Treatment of patients with lipid disorders (ICD10: E78.01, I21, I22, I25)" Decision-making problem: preparing a position paper on the evaluation of the drug

2. Vercyte (pipobroman) Indication: verrucous melanoma Decision problem: preparation of a position on the appropriateness of granting reimbursement approval for a medicinal product

3. acidum zoledronicum Indication: complementary postoperative treatment with zoledronic acid of postmenopausal breast cancer patients Decision-making problem: preparation of opinion on continuation of reimbursement coverage in off-label indications

4. Invokana (Canagliflozinum) CONDITIONAL Indication: type 2 diabetes in patients treated with at least two hypoglycemic drugs, with HbA1c ≥ 7.0% and very high cardiovascular risk defined as:

1) confirmed cardiovascular disease, or

2) damage to other organs manifested by: proteinuria or left ventricular hypertrophy or retinopathy, or

3) presence of 3 or more major risk factors among the following: -age ≥ 55 for men, ≥60 for women, -dyslipidemia, -hypertension, -smoking, -obesity Decision problem: preparing a position paper on drug evaluation

5. "Program for the prevention of overweight and obesity in children of class III from elementary school run by the Municipality of Swidwin for 2024-2026". Decision-making problem: preparation of an opinion on the draft health policy program of the local government unit

6. "Health policy program on early detection of eye defects in children from Poznań district" Decision-making problem: preparation of an opinion on the draft health policy program of a local government unit

TRANSPARENCY COUNCIL MEETING NO. 46/2023 NOVEMBER 20, 2023

1. Jardiance (empagliflozinum) Indication: chronic kidney disease in adult patients with: eGFR in the range of ≥ 20 ml/min/1.73 m2 to < 45 ml/min/1.73 m2, taking ACEi/ARB-based therapy for at least 4 weeks or with a contraindication to such therapy, or eGFR in the range of ≥ 45 ml/min/1.73 m2 to < 90 ml/min/1.73 m2 and albuminuria or proteinuria, taking ACEi/ARB-based therapy for at least 4 weeks or with a contraindication to such therapy Decision problem: Preparation of a position paper on drug evaluation

2. "Health policy program on prevention of breast cancer for residents of Grębocice" Decision-making problem: preparing an opinion on the draft health policy program of the local government unit

3. health policy program "Treatment of infertility by in vitro fertilization for residents of the Municipality of Starogard Gdański in 2024-2027 Decision-making problem: preparation of an opinion on the draft health policy program of the local government unit

TRANSPARENCY COUNCIL MEETING NO. 47/2023 NOVEMBER 27, 2023

1. health policy program "Healthier Kolobrzeg - treatment of infertility by in vitro method, securing fertility Decision-making problem: preparation of an opinion on the draft health policy program of the local government unit

2. "Health policy program for therapeutic rehabilitation of residents of the municipality of Ozarow" Decision-making problem: preparing an opinion on the draft health policy program of the local government unit

3. "Preventive health program of vaccination against meningococcus serogroup C, A, W and Y for children aged 6 years from the territory of the district of Znin" Decision-making problem: preparation of an opinion on the draft health policy program of the local government unit.

Source: AOTMiT

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Lub znajdź wyjątkowe miejsce pracy!

Read also